Clinical Trials Browser

Phase 1/2 × Completed × Ribavirin × Clear all

NCT01056523 2023-10-02

Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

Phase 1/2 Completed

29 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute